← Back to Patent Explorer
US4656139A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for preparing cells for blood analysis

Assignee: Sysmex Corp
•
Filing: 1986-06-30
•
Granted: 1987-04-07
•
Expires: 2006-06-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A reagent for blood analysis comprises, as a lysing reagent for leukocyte count, tetradecyltrimethylammonium bromide and/or hexadecyltrimethylammonium chloride, dodecyltrimethylammonium chloride, and citric acid. This reagent is characterized by showing three-peaks fractionation of leukocytes in measuring by means of an automatic blood-analysis instrument. The lysing reagent is used together with a diluent comprising boric acid buffer solution, ethylenediaminetetraacetic acid and (2-pyridylthio-1-oxide) sodium.

Inventors

  • 👤 Noriaki Matsuda
  • 👤 Etsuro Shinkai

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 18:11
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; G01N33/5094; G01N33/53; G01N33/569; G01N33/56966; G01N33/56972; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/101666; Y10T436/107497; Y10T436/108331

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 59 words
A method for preparing cells for blood analysis comprising the stpes of: diluting a blood sample with a diluent comprising boric acid buffer solution, ethylenediaminetetraacetic acid and (2-pyridylthio-1-oxide) sodium, and treating the diluted blood with a lysing reagent comprising dodecyltrimethylammonium chloride; citric acid; and at least one member selected from the group consisting of tetradecyltrimethylammonium bromide and hexadecyltrimethylammonium chloride.
Claim 2
Independent Claim 59 words
A method for preparing cells for blood analysis comprising the stpes of: diluting a blood sample with a diluent comprising boric acid buffer solution, ethylenediaminetetraacetic acid and (2-pyridylthio-1-oxide) sodium, and treating the diluted blood with a lysing reagent comprising dodecyltrimethylammonium chloride; citric acid; and at least one member selected from the group consisting of tetradecyltrimethylammonium bromide and hexadecyltrimethylammonium chloride.

References Cited (Backward Citations)

US3519572A Cited
US3874852A Cited
US3874852B1 Cited
US4185964A Cited
US4248634A Cited
US4264470A Cited
US4286963A Cited
US4346018A Cited
US4521518A Cited
US4485174A Cited
US4529705A Cited
US4575490A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-04-06 1990-10-06 1991-04-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-04-06 1994-10-06 1995-04-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-04-06 1998-10-06 1999-04-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag